Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV
The Effect of an Enhanced Rice Bran Nutritional Supplement on Metabolic Syndrome Variables in HIV
Status: Enrolling
Updated:  12/1/2015
University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences
mi
from
Miami, FL
The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV
The Effect of an Enhanced Rice Bran Nutritional Supplement on Metabolic Syndrome Variables in HIV
Status: Enrolling
Updated: 12/1/2015
University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status: Enrolling
Updated:  12/2/2015
University of Washington Virology Research Clinic
mi
from
Seattle, WA
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status: Enrolling
Updated: 12/2/2015
University of Washington Virology Research Clinic
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated:  12/2/2015
NYU School of Medicine
mi
from
New York, NY
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated: 12/2/2015
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated:  12/2/2015
The Lung Institute at University of Cape Town
mi
from
Cape Town,
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome
Status: Enrolling
Updated: 12/2/2015
The Lung Institute at University of Cape Town
mi
from
Cape Town,
Click here to add this to my saved trials
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
Silicon Phthalocyanine Pc4 for Photodynamic Therapy of Cutaneous T-cell Lymphoma: Single and Repeated Photoexposures
Status: Enrolling
Updated:  12/3/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
Silicon Phthalocyanine Pc4 for Photodynamic Therapy of Cutaneous T-cell Lymphoma: Single and Repeated Photoexposures
Status: Enrolling
Updated: 12/3/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Bon Secours Health System
mi
from
Richmond, VA
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Bon Secours Health System
mi
from
Richmond, VA
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Clinical Research Solutions
mi
from
Jackson, TN
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Clinical Research Solutions
mi
from
Jackson, TN
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Digestive Health Care
mi
from
Ocean Springs, MS
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Digestive Health Care
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
JM Research
mi
from
Houston, TX
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
JM Research
mi
from
Houston, TX
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Montefiore Hospital
mi
from
Bronx, NY
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Montefiore Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Omega Medical Research
mi
from
Warwick, RI
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated:  12/3/2015
Henry Ford Health System
mi
from
Detroit, MI
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
Status: Enrolling
Updated: 12/3/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Tuberculosis Research Blood Bank
Status: Enrolling
Updated:  12/7/2015
NYU School of Medicine Division of Pulmonary and Critical Care Medicine
mi
from
New York, NY
Tuberculosis Research Blood Bank
Status: Enrolling
Updated: 12/7/2015
NYU School of Medicine Division of Pulmonary and Critical Care Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome
Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome
Status: Enrolling
Updated:  12/7/2015
VA Harbor Simulation Center
mi
from
New York, NY
Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome
Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome
Status: Enrolling
Updated: 12/7/2015
VA Harbor Simulation Center
mi
from
New York, NY
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Birmingham, AL
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Stanford, CA
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Denver, CO
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Washington,
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Gainsville, FL
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Gainsville, FL
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Miami, FL
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Tampa, FL
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Kansas City, KA
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Bethesda, MD
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Rochester, MN
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
New York, NY
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Cleveland, OH
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Portland, OR
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Charleston, SC
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Tyler, TX
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated:  12/8/2015
mi
from
Toronto,
Arikayce for Nontuberculous Mycobacteria
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce®) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
Status: Enrolling
Updated: 12/8/2015
mi
from
Toronto,
Click here to add this to my saved trials
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
The Impact of Electroencephalographic (EEG) Seizure Treatment in Near Term ≥ 36 Weeks Gestation and Term Infants With Neonatal Encephalopathy
Status: Enrolling
Updated:  12/8/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
The Impact of Electroencephalographic (EEG) Seizure Treatment in Near Term ≥ 36 Weeks Gestation and Term Infants With Neonatal Encephalopathy
Status: Enrolling
Updated: 12/8/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated:  12/8/2015
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated: 12/8/2015
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Randomized Control Trial of Family-Based HIV Prevention for Latinos
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated:  12/8/2015
University of South Florida
mi
from
Tampa, FL
Randomized Control Trial of Family-Based HIV Prevention for Latinos
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated: 12/8/2015
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
Status: Enrolling
Updated:  12/9/2015
University of Colorado, Boulder Clinical Translational Research Center
mi
from
Boulder, CO
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
Status: Enrolling
Updated: 12/9/2015
University of Colorado, Boulder Clinical Translational Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Status: Enrolling
Updated:  12/9/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Status: Enrolling
Updated: 12/9/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Status: Enrolling
Updated:  12/11/2015
Denver VA
mi
from
Denver, CO
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Status: Enrolling
Updated: 12/11/2015
Denver VA
mi
from
Denver, CO
Click here to add this to my saved trials
Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 2 Virus Vaccine, rHPIV2 15C/948L/Δ1724 Lot PIV2#109C, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV2-Seropositive Children 15 to 59 Months of Age, and HPIV2-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated:  12/14/2015
Johns Hopkins University, Bloomberg School of Public Health
mi
from
Baltimore, MD
Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 2 Virus Vaccine, rHPIV2 15C/948L/Δ1724 Lot PIV2#109C, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV2-Seropositive Children 15 to 59 Months of Age, and HPIV2-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated: 12/14/2015
Johns Hopkins University, Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Penfield Pediatrics
mi
from
Penfield, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Penfield Pediatrics
mi
from
Penfield, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Westfall Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Westfall Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Lewis Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Lewis Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Sunrise Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Sunrise Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Legacy Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Legacy Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated:  12/14/2015
Pathway Pediatrics
mi
from
Rochester, NY
Effect of Prevnar 13 on Ear Infections in Children
"a Phase 4, Postmarketing Study Evaluating The Impact Of Prevnar 13 (Trademark)(13-valent Pneumococcal Conjugate Vaccine; 13vpnc) In Reducing Acute Otitis Media And Nasopharyngeal Colonization Caused By Streptococcus Pneumoniae In Healthy Children
Status: Enrolling
Updated: 12/14/2015
Pathway Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV MEDI ΔM2-2 Lot RSV#002A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, RSV-Seropositive Children 12 to 59 Months of Age, and RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated:  12/14/2015
John Hopkins Center for Immunization Research
mi
from
Baltimore, MD
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV MEDI ΔM2-2 Lot RSV#002A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, RSV-Seropositive Children 12 to 59 Months of Age, and RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated: 12/14/2015
John Hopkins Center for Immunization Research
mi
from
Baltimore, MD
Click here to add this to my saved trials